Ann & Robert H Lurie Children's Hospital of Chicago
285
55
72
163
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
8.1%
23 terminated/withdrawn out of 285 trials
87.6%
+1.1% vs industry average
5%
14 trials in Phase 3/4
26%
42 of 163 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (285)
MyPEEPS Mobile Plus: A Multi-Level HIV Prevention Intervention for Young MSM
Role: collaborator
Hospital Based Continuous Patient Monitoring System
Role: collaborator
Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies
Role: collaborator
Early Detection of Infection Using the Fitbit in Pediatric Surgical Patients
Role: lead
Rise & Thrive: Community-Engagement Intervention for Stress and Depression in Youth.
Role: lead
Using Information Technology to Improve Outcomes for Children Living With Cancer
Role: collaborator
Tiny Cargo, Big Deal! An ED-Based Study of Child Passenger Safety Behaviors
Role: lead
Genetic Information for Families After Tumor Testing Study
Role: collaborator
Observation Study in Patients Age 0-5 Years With LAMA2-related Congenital Muscular Dystrophy
Role: collaborator
Intervention to Reduce Early (Peanut) Allergy in Children
Role: lead
DBT-P Treatment Study
Role: collaborator
Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
Role: collaborator
Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW
Role: collaborator
Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients
Role: lead
Wearable Sensors to Detect Atypical Muscle Activation in Young Infants
Role: collaborator
Exercise in Child Health
Role: collaborator
Prospective Multisite Study of Quality of Life in Pediatric Intestinal Failure
Role: collaborator
Eosinophilic Gastrointestinal Disorders Registry
Role: lead
Efficacy of Low-Dose Topical Steroids in Maintaining Remission of Eosinophilic Esophagitis in Children
Role: lead
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
Role: lead